当前位置:光动力医学科技网 > 专题文献  

 

光动力医学科技网
基础研究类
临床应用类
综述文献类

 

 

 
     
 

光动力治疗膀胱癌外文文献
       —基础研究类

  说明:为便于广大读者了解国际上在光动力治疗膀胱癌基础研究领域的发展历程与目前进展,我们搜集了以下资料供大家参考。

  资料按发表年代排列,同一年内按第一作者字母顺序排列。

  发表时间

 2003年

Manivasager V, Heng PW, Hao J, Zheng W, Soo KC, Olivo M.
A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer.
Int J Oncol. 2003 Feb;22(2):313-8.

Olivo M, Lau W, Manivasager V, Hoon TP, Christopher C.
Fluorescence confocal microscopy and image analysis of bladder cancer using 5-aminolevulinic acid.
Int J Oncol. 2003 Mar;22(3):523-8.

Ridgway TD, Lucroy MD. 光动力医学科技网
Phototoxic effects of 635-nm light on canine transitional cell carcinoma cells incubated with 5-aminolevulinic acid.
Am J Vet Res. 2003 Feb;64(2):131-6.

Xiao Z, Brown K, Tulip J, Moore RB.
Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
J Urol. 2003 Jan;169(1):352-6.

TOP


 2002年

Ali SM, Chee SK, Yuen GY, Olivo M.
Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells.
Int J Mol Med. 2002 Jun;9(6):601-16.

Ali SM, Olivo M.光动力医学科技网
Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Int J Oncol. 2002 Sep;21(3):531-40.

Bisson JF, Christophe M, Padilla-Ybarra JJ, Notter D, Vigneron C, Guillemin F.
Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ.
Anticancer Drugs. 2002 Sep;13(8):851-7.

Bisson JF, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F.
A new method of implanting orthotopic rat bladder tumor for experimental therapies.
Int J Cancer. 2002 Nov 20;102(3):280-5.

Chen Q, Huang Z, Luck D, Beckers J, Brun PH, Wilson BC, Scherz A, Salomon Y, Hetzel FW.
Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
Photochem Photobiol. 2002 Oct;76(4):438-45.

Droller MJ. 光动力医学科技网
Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.
J Urol. 2002 Aug;168(2):856.

Gronlund-Pakkanen S, Wahlfors J, Makinen K, Pakkanen TM, Talja M, Ala-Opas M, Alhava E, Moore RB.
The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
J Urol. 2002 Apr;167(4):1848-53.

Murugesan S, Shetty SJ, Srivastava TS, Samuel AM, Noronha OP.
Preparation and biological evaluation of the new chlorin photosensitizer T3,4BCPC for detection and treatment of tumors.
J Photochem Photobiol B. 2002 Aug;68(1):33-8.

Pytel A, Schmeller N. 光动力医学科技网
New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology.
Urology. 2002 Feb;59(2):216-9.

Schaffer M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A, Jori G, Duhmke E.
Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
J Photochem Photobiol B. 2002 Apr;66(3):157-64.

Shackley DC, Haylett A, Whitehurst C, Betts CD, O'Flynn K, Clarke NW, Moore JV.
Comparison of the cellular molecular stress responses after treatments used in bladder cancer.
BJU Int. 2002 Dec;90(9):924-32.

Van Staveren HJ, Beek JF, Verlaan CW, Edixhoven A, De Reijke TM, Brutel De La RiviERe G, Star WM.
Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA.
Lasers Med Sci. 2002;17(4):238-45.

Xiao Z, Tamimi Y, Brown K, Tulip J, Moore R.
Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid.光动力医学科技网
Urol Oncol. 2002 May-Jun;7(3):125-32.

TOP


 2001年

Ali SM, Chee SK, Yuen GY, Olivo M.
Hypericin and hypocrellin induced apoptosis in human mucosal carcinoma cells.
J Photochem Photobiol B. 2001 Dec 1;65(1):59-73.

Ali SM, Olivo M, Yuen GY, Chee SK.
Induction of apoptosis by Hypericin through activation of caspase-3 in human carcinoma cells.
Int J Mol Med. 2001 Nov;8(5):521-30.

Gronlund-Pakkanen S, Pakkanen TM, Koski E, Talja M, Ala-Opas M, Alhava E.
Effect of photodynamic therapy on urinary bladder function: an experimental study with rats.
Urol Res. 2001 Jun;29(3):205-9.

Hsi RA, Kapatkin A, Strandberg J, Zhu T, Vulcan T, Solonenko M, Rodriguez C, Chang J, Saunders M, Mason N, Hahn S. 光动力医学科技网
Photodynamic therapy in the canine prostate using motexafin lutetium.
Clin Cancer Res. 2001 Mar;7(3):651-60.

Kamuhabwa AR, Agostinis PM, D'Hallewin MA, Baert L, de Witte PA.
Cellular photodestruction induced by hypericin in AY-27 rat bladder carcinoma cells.
Photochem Photobiol. 2001 Aug;74(2):126-32.

Korbelik M, Sun J, Posakony JJ.
Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
Photochem Photobiol. 2001 Apr;73(4):403-9.

Lange N, Vaucher L, Marti A, Etter AL, Gerber P, van Den Bergh H, Jichlinski P, Kucera P.
Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia.
J Biomed Opt. 2001 Apr;6(2):151-9.

Schaffer M, Schaffer PM, Corti L, Sotti G, Hofstetter A, Jori G, Duhmke E.
Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
Onkologie. 2001 Oct;24(5):482-5.光动力医学科技网

Seidl J, Rauch J, Krieg RC, Appel S, Baumgartner R, Knuechel R.
Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer.
Int J Cancer. 2001 Jun 1;92(5):671-7.

Singh G, Espiritu M, Shen XY, Hanlon JG, Rainbow AJ.
In vitro induction of PDT resistance in HT29, HT1376 and SK-N-MC cells by various photosensitizers.
Photochem Photobiol. 2001 Jun;73(6):651-6.

Wyld L, Reed MW, Brown NJ.
Differential cell death response to photodynamic therapy is dependent on dose and cell type.
Br J Cancer. 2001 May 18;84(10):1384-6.

TOP


 2000年

Chang S, Chern I, Bown SG.
Photodynamic therapy of rat bladder and urethra: evaluation of urinary and reproductive function after inducing protoporphyrin IX with 5-aminolaevulinic acid.光动力医学科技网
BJU Int. 2000 Apr;85(6):747-53.

Cosserat-Gerardin I, Bezdetnaya L, Notter D, Vigneron C, Guillemin F.
Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells.
J Photochem Photobiol B. 2000 Dec;59(1-3):72-9.

Gronlund-Pakkanen S, Pakkanen TM, Talja M, Kosma VM, Ala-Opas M, Alhava E.
The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX.
BJU Int. 2000 Jul;86(1):126-32.

Kamuhabwa AR, Agostinis P, D'Hallewin MA, Kasran A, de Witte PA.
Photodynamic activity of hypericin in human urinary bladder carcinoma cells.
Anticancer Res. 2000 Jul-Aug;20(4):2579-84.

Krieg RC, Fickweiler S, Wolfbeis OS, Knuechel R.
Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.
Photochem Photobiol. 2000 Aug;72(2):226-33.

Ruck A, Heckelsmiller K, Kaufmann R, Grossman N, Haseroth E, Akgun N.
Light-induced apoptosis involves a defined sequence of cytoplasmic and nuclear calcium release in AlPcS4-photosensitized rat bladder RR 1022 epithelial cells.光动力医学科技网
Photochem Photobiol. 2000 Aug;72(2):210-6.

Shackley DC, Whitehurst C, Moore JV, George NJ, Betts CD, Clarke NW.
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours.
BJU Int. 2000 Oct;86(6):638-43.

Uehlinger P, Zellweger M, Wagnieres G, Juillerat-Jeanneret L, van den Bergh H, Lange N.
5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells.
J Photochem Photobiol B. 2000 Jan;54(1):72-80.

van den Akker JT, Iani V, Star WM, Sterenborg HJ, Moan J.
Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.光动力医学科技网
Photochem Photobiol. 2000 Nov;72(5):681-9.

TOP


 1999年

Beck TP, Kirsh EJ, Chmura SJ, Kovar DA, Chung T, Rinker-Schaeffer CW, Stadler WM.
In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
Urology. 1999 Sep;54(3):573-7.

Iinuma S, Schomacker KT, Wagnieres G, Rajadhyaksha M, Bamberg M, Momma T, Hasan T.
In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
Cancer Res. 1999 Dec 15;59(24):6164-70.

Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P.
Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach.
J Urol. 1999 Aug;162(2):546-52.

TOP


 1998年光动力医学科技网

Datta SN, Loh CS, MacRobert AJ, Whatley SD, Matthews PN.
Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma.
Br J Cancer. 1998 Oct;78(8):1113-8.

van den Boogert J, van Hillegersberg R, de Rooij FW, de Bruin RW, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JH, Tilanus HW.
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration.
J Photochem Photobiol B. 1998 Jun 15;44(1):29-38.

Wyld L, Reed MW, Brown NJ. 光动力医学科技网
The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
Br J Cancer. 1998 May;77(10):1621-7.

Wyld L, Smith O, Lawry J, Reed MW, Brown NJ.
Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.
Br J Cancer. 1998 Jul;78(1):50-5.

TOP


 1997年

Bech O, Phillips D, Moan J, MacRobert AJ.
A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells.
J Photochem Photobiol B. 1997 Nov;41(1-2):136-44.

Chang SC, Buonaccorsi G, MacRobert AJ, Bown SG.
5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Lasers Surg Med. 1997;20(3):254-64.

Chang SC, MacRobert AJ, Porter JB, Bown SG.
The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
J Photochem Photobiol B. 1997 Apr;38(2-3):114-22.

Datta SN, Allman R, Loh CS, Mason M, Matthews PN.
Photodynamic therapy of bladder cancer cell lines.
Br J Urol. 1997 Sep;80(3):421-6.

Datta SN, Allman R, Loh C, Mason M, Matthews PN.
Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
Br J Cancer. 1997;76(3):312-7.

Gronlund-Pakkanen S, Makinen K, Talja M, Kuusisto A, Alhava E.
The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy.
J Photochem Photobiol B. 1997 Apr;38(2-3):269-73.

Marcinkowska E, Ziolkowski P, Pacholska E, Latos-Grazynski L, Chmielewski P, Radzikowski C.
The new sensitizing agents for photodynamic therapy: 21-selenaporphyrin and 21-thiaporphyrin.
Anticancer Res. 1997 Sep-Oct;17(5A):3313-9.

Muller M, Reich E, Steiner U, Heicappell R, Miller K.
Photodynamic effects of sulfonated aluminum chlorophthalocyanine in human urinary bladder carcinoma cells in vitro.
Eur Urol. 1997;32(3):339-43.

Stocker S, Knuchel R, Sroka R, Kriegmair M, Steinbach P, Baumgartner R.
Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid.
J Urol. 1997 Jan;157(1):357-61.

van Staveren HJ, Bertrams RH, Star WM.
Bladder PDT with intravesical clear and light scattering media: effect of an eccentric isotropic light source on the light distribution. 光动力医学科技网
Lasers Surg Med. 1997;20(3):248-53.

TOP


1996年

Bachor R, Reich E, Ruck A, Hautmann R.
Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.
Urol Res. 1996;24(5):285-9.

Beyer W. 光动力医学科技网
Systems for light application and dosimetry in photodynamic therapy.
J Photochem Photobiol B. 1996 Nov;36(2):153-6.

Chang SC, MacRobert AJ, Bown SG.
Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes.
J Urol. 1996 May;155(5):1749-53.

Chang SC, MacRobert AJ, Bown SG.
Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.
J Urol. 1996 May;155(5):1744-8.

Egger NG, Motamedi M, Pow-Sang M, Orihuela E, Anderson KE.
Accumulation of porphyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: implications for photodynamic therapy.
Pharmacology. 1996 Jun;52(6):362-70.

Post JG, te Poele JA, Schuitmaker JJ, Stewart FA.
A comparison of functional bladder damage after intravesical photodynamic therapy with three different photosensitizers.
Photochem Photobiol. 1996 Mar;63(3):314-21.

Riesenberg R, Fuchs C, Kriegmair M.
Photodynamic effects of 5-aminolevulinic acid-induced porphyrin on human bladder carcinoma cells in vitro.
Eur J Cancer. 1996 Feb;32A(2):328-34.

Ruck A, Beck G, Bachor R, Akgun N, Gschwend MH, Steiner R.
Dynamic fluorescence changes during photodynamic therapy in vivo and in vitro of hydrophilic A1(III) phthalocyanine tetrasulphonate and lipophilic Zn(II) phthalocyanine administered in liposomes.
J Photochem Photobiol B. 1996 Nov;36(2):127-33.

van Staveren HJ, Keijzer M, Keesmaat T, Jansen H, Kirkel WJ, Beek JF, Star WM.
Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties.
Phys Med Biol. 1996 Apr;41(4):579-90.

Zuk MM, Rihter BD, Kenney ME, Rodgers MA, Kreimer-Birnbaum M.
Effect of delivery system on the pharmacokinetics and tissue distribution of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC), a photosensitizer for tumor therapy.
Photochem Photobiol. 1996 Jan;63(1):132-40.

TOP


1995年

Bachor R, Reich E, Miller K, Ruck A, Hautmann R.
Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines.
Urol Res. 1995;23(3):151-6.

Iinuma S, Bachor R, Flotte T, Hasan T.
Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
J Urol. 1995 Mar;153(3 Pt 1):802-6.

Post JG, te Poele JA, Oussoren Y, Stewart FA.
The influence of intravesical photodynamic therapy on subsequent bladder irradiation tolerance.
Radiother Oncol. 1995 Nov;37(2):124-30.

Star WM. 光动力医学科技网
The relationship between integrating sphere and diffusion theory calculations of fluence rate at the wall of a spherical cavity.
Phys Med Biol. 1995 Jan;40(1):1-8.

Tanaka M, Uchibayashi T, Obata T, Sasaki T.
Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors.
Cancer Lett. 1995 Apr 14;90(2):163-9.

van Staveren HJ, Beek JF, Keijzer M, Star WM.
Integrating sphere effect in whole-bladder-wall photodynamic therapy: II. The influence of urine at 458, 488, 514 and 630 nm optical irradiation.光动力医学科技网
Phys Med Biol. 1995 Aug;40(8):1307-15.

VanDerWal J, Lagerberg WM, Dubbelman TM, VanSteveninck J.
Interaction of photodynamically induced cell killing and dark cytotoxicity of rhodamine 123.
Photochem Photobiol. 1995 Oct;62(4):757-63.

TOP


1994年

Aicher A, Miller K, Reich E, Hautmann R.
Photodynamic therapy of human bladder carcinoma cells in vitro with pH-sensitive liposomes as carriers for 9-acetoxy-tetra-n-propylporphycene.
Urol Res. 1994;22(1):25-32.

Bachor R, Hautmann R, Hasan T.
Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer.
Urol Res. 1994;22(1):21-3.

Bergstrom LC, Vucenik I, Hagen IK, Chernomorsky SA, Poretz RD.
In-vitro photocytotoxicity of lysosomotropic immunoliposomes containing pheophorbide a with human bladder carcinoma cells.
J Photochem Photobiol B. 1994 Jun;24(1):17-23.

Haselhuhn GD, Kropp KA, Keck RW, Selman SH.
Photochemical ablation of intestinal mucosa for bladder augmentation.
J Urol. 1994 Dec;152(6 Pt 2):2267-71.

Hayashi O, Akashi M, Fujime M, Hanazawa K, Kitagawa R.
Detection of interleukin-1 activity in human bladder cancer cell lines.
J Urol. 1994 Mar;151(3):750-3.

Leveckis J, Burn JL, Brown NJ, Reed MW.
Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder.
J Urol. 1994 Aug;152(2 Pt 1):550-3.

Penning LC, Tijssen K, VanSteveninck J, Dubbelman TM.
Hematoporphyrin derivative-induced photodynamic inhibition of Na+/K(+)-ATPase in L929 fibroblasts, Chinese hamster ovary cells and T24 human bladder transitional carcinoma cells.
Photochem Photobiol. 1994 Mar;59(3):336-41.

Steinbach P, Kriegmair M, Baumgartner R, Hofstadter F, Knuchel R.
Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
Urology. 1994 Nov;44(5):676-81.

TOP


1993年

Bellnier DA, Henderson BW, Pandey RK, Potter WR, Dougherty TJ.
Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
J Photochem Photobiol B. 1993 Sep;20(1):55-61.

Konig K, Genze F, Miller K, Ruck A, Reich E, Repassy D.
Photodynamic activity of liposome-delivered Cd-texaphyrin using tumor-bearing nude mice.
Lasers Surg Med. 1993;13(5):522-7.

Konig K, Schneckenburger H, Ruck A, Steiner R.
In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins.
J Photochem Photobiol B. 1993 May;18(2-3):287-90.

Koshida K, Hisazumi H, Komatsu K, Hirata A, Uchibayashi T.
Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy.
Urol Res. 1993;21(4):283-8.

Leveckis J, Burn JL, Brown NJ, Reed MW.
Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder.
J Urol. 1994 Aug;152(2 Pt 1):550-3.

Marijnissen JP, Star WM, in 't Zandt HJ, D'Hallewin MA, Baert L.
In situ light dosimetry during whole bladder wall photodynamic therapy: clinical results and experimental verification.
Phys Med Biol. 1993 May;38(5):567-82.

Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG.
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Br J Cancer. 1993 Jul;68(1):41-51.

Nseyo UO, Whalen RK, Lundahl SL.
Canine bladder response to red and green light whole bladder photodynamic therapy.
Urology. 1993 Apr;41(4):392-6.光动力医学科技网

Penning LC, Keirse MJ, VanSteveninck J, Dubbelman TM.
Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin- derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro.
Biochem J. 1993 May 15;292 ( Pt 1):237-40.

Penning LC, VanSteveninck J, Dubbelman TM.
HPD-induced photodynamic changes in intracellular cyclic AMP levels in human bladder transitional carcinoma cells, clone T24.
Biochem Biophys Res Commun. 1993 Aug 16;194(3):1084-9.

Roberts WG, Hasan T. 光动力医学科技网
Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Cancer Res. 1993 Jan 1;53(1):153-7.

Selman SH, Hampton JA, Morgan AR, Keck RW, Balkany AD, Skalkos D.
Copper benzochlorin, a novel photosensitizer for photodynamic therapy: effects on a transplantable urothelial tumor.
Photochem Photobiol. 1993 Apr;57(4):681-5.

Stewart FA, Oussoren Y. 光动力医学科技网
Functional and histological bladder damage in mice after photodynamic therapy: the influence of sensitiser dose and time of administration.
Br J Cancer. 1993 Oct;68(4):673-7.

Windahl T, Peng Q, Moan J, Hellsten S, Axelsson B, Lofgren L.
Uptake and distribution of intravenously or intravesically administered photosensitizers in the rat.
Cancer Lett. 1993 Nov 30;75(1):65-70.

Yu DS, Chang SY, Ma CP.
The effect of methylene blue-sensitized photodynamic treatment on bladder cancer cells: a further study on flow cytometric basis.
J Urol. 1993 May;149(5):1198-201.

TOP


1992年

Bachor R, Flotte TJ, Scholz M, Dretler S, Hasan T.
Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
J Urol. 1992 May;147(5):1404-10.

Cho YH, Straight RC, Smith JA Jr.
Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model.
J Urol. 1992 Mar;147(3):743-6.

Morgan AR, Skalkos D, Maguire G, Rampersaud A, Garbo G, Keck R, Selman SH.
Observations on the synthesis and in vivo photodynamic activity of some benzochlorins.
Photochem Photobiol. 1992 Jan;55(1):133-6.

Penning LC, Rasch MH, Ben-Hur E, Dubbelman TM, Havelaar AC, Van der Zee J, Van Steveninck J.
A role for the transient increase of cytoplasmic free calcium in cell rescue after photodynamic treatment.
Biochim Biophys Acta. 1992 Jun 30;1107(2):255-60.

Prinsze C, Penning LC, Dubbelman TM, VanSteveninck J.
Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder carcinoma cells.
Cancer Res. 1992 Jan 1;52(1):117-20.

Stewart FA, Oussoren Y, te Poele JA, Horenblas S, Mooi WJ.
Functional and histological damage in the mouse bladder after photodynamic therapy.
Br J Cancer. 1992 Jun;65(6):884-90.

Taari K, Talja M, Riihela M, Rannikko S, Mokka R.
Morphological effects of photodynamic therapy on rabbit bladder using Photofrin II and Photosan intravesically and intravenously.
Br J Urol. 1992 Dec;70(6):616-21.

Tolentino M, Okunaka T, Eckhauser ML, Yamamoto H, Kato H, Valencic F, Fleischmann JD, Sarasua MM, Koehler KA.
A new porphyrin photosensitizer (PH1008) in model membranes, normal cells, and bladder cancer cells.
J Urol. 1992 Oct;148(4):1338-40.

TOP


1991年

Bachor R, Scholz M, Shea CR, Hasan T.
Mechanism of photosensitization by microsphere-bound chlorin e6 in human bladder carcinoma cells.
Cancer Res. 1991 Aug 15;51(16):4410-4.

Bachor R, Shea CR, Belmonte SJ, Hasan T.
Free and conjugated chlorin E6 in the photodynamic therapy of human bladder carcinoma cells.
J Urol. 1991 Dec;146(6):1654-8.

Bachor R, Shea CR, Gillies R, Hasan T.
Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres.
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1580-4.

Komatsu K. 光动力医学科技网
Photodynamic cell killing effects and acute skin photosensitivity of aluminum-chloro-tetrasulfonated phthalocyanine and hematoporphyrin derivative.
Jpn J Cancer Res. 1991 May;82(5):599-606.

He DP, Hampton JA, Keck R, Selman SH.
Photodynamic therapy: effect on the endothelial cell of the rat aorta.
Photochem Photobiol. 1991 Nov;54(5):801-4.

Lin CW, Shulok JR, Kirley SD, Cincotta L, Foley JW.
Lysosomal localization and mechanism of uptake of Nile blue photosensitizers in tumor cells.
Cancer Res. 1991 May 15;51(10):2710-9.

Lin CW, Shulok JR, Wong YK, Schanbacher CF, Cincotta L, Foley JW.
Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells.
Cancer Res. 1991 Feb 15;51(4):1109-16.

Miller K, Reich E, Ruck A, Hautmann R.
Photodynamic therapy of bladder cancer--uptake and phototoxicity of photosan in vitro.
Urol Res. 1991;19(6):353-6.

Morgan AR, Skalkos D, Garbo GM, Keck RW, Selman SH.
Synthesis and in vivo photodynamic activity of some bacteriochlorin derivatives against bladder tumors in rodents.
J Med Chem. 1991 Jul;34(7):2126-33.

Pope AJ, Bown SG.
The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization.
J Urol. 1991 May;145(5):1064-70.

Pope AJ, MacRobert AJ, Phillips D, Bown SG.
The detection of phthalocyanine fluorescence in normal rat bladder wall using sensitive digital imaging microscopy.
Br J Cancer. 1991 Nov;64(5):875-9.

Recker F, Otto T. 光动力医学科技网
Animal experiment aspects of bladder cancer.
Urologe A. 1991 May;30(3):172-9. 综述(德文)

Selman SH, Fitkin DL, Keck RW, Morgan AR, Doiron DR.
Treatment of the transplantable FANFT induced bladder tumors with the purpurin SnET2 and red light emitted by a pulsed frequency doubled Nd:YAG laser.
J Laser Appl. 1991 Spring;3(2):45-8.

Tseng MT, Schuschke DA, Reed MW, Harty JI, Wieman TJ, Fingar VH.
The influence of photodynamic therapy on the ultrastructure of the normal rat bladder.
J Photochem Photobiol B. 1991 Jun;9(3-4):295-305.

Yu DS, Chang SY, Ma CP. 光动力医学科技网
Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment.
Eur Urol. 1991;19(4):322-6.

TOP


1990年

Fowler GJ, Rees RC, Devonshire R.
The photokilling of bladder carcinoma cells in vitro by phenothiazine dyes.
Photochem Photobiol. 1990 Sep;52(3):489-94.

Hisazumi H, Hirata A, Uchibayashi T, Naito K, Miyoshi N.
Phthalocyanine: a new photosensitizer in photodynamic therapy.
Gan To Kagaku Ryoho. 1990 Jun;17(6):1120-6. (日文)

Guo YC. 光动力医学科技网
Improved argon laser photodynamic therapy for superficial bladder tumor--experimental research and clinical analysis.
Zhonghua Zhong Liu Za Zhi. 1990 Jan;12(1):75-7. (中文)

McCaughan L.
Lasers in photodynamic therapy.
Nurs Clin North Am. 1990 Sep;25(3):725-38.

Morgan AR, Garbo GM, Keck RW, Skalkos D, Selman SH.
Synthesis and in vivo activity of some porphyrindione derivatives with potential in photodynamic therapy.
J Photochem Photobiol B. 1990 Jun;6(1-2):133-41.

Morgan AR, Garbo GM, Keck RW, Eriksen LD, Selman SH.
Metallopurpurins and light: effect on transplantable rat bladder tumors and murine skin.
Photochem Photobiol. 1990 May;51(5):589-92.

Morgan AR, Garbo GM, Keck RW, Miller RA, Selman SH, Skalkos D.
Diels-Alder adducts of vinyl porphyrins: synthesis and in vivo photodynamic effect against a rat bladder tumor.
J Med Chem. 1990 Apr;33(4):1258-62.

Nseyo UO, Whalen RK, Duncan MR, Berman B, Lundahl SL.
Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report.
Urology. 1990 Aug;36(2):167-71.

Pope AJ, Masters JR, MacRobert AJ.
The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro.
Urol Res. 1990;18(4):267-70.光动力医学科技网

Selman SH, Qin BS, James HR, Keck RW, Garbo GM, Morgan AR.
Hemodynamic effect of the metallopurpurin SnET2 and light on transplantable FANFT induced bladder tumor.
J Urol. 1990 Mar;143(3):630-3.

TOP


 1989年

Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ.
Distribution and elimination of Photofrin II in mice.
Photochem Photobiol. 1989 Aug;50(2):221-8.

Broghamer WL Jr, Parker JE, Harty JI, Gilkey CM.
Cytohistologic correlation of urothelial lesions secondary to photodynamic therapy.
Acta Cytol. 1989 Nov-Dec;33(6):881-6.

Henderson BW, Bellnier DA. 光动力医学科技网
Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction.
Ciba Found Symp. 1989;146:112-25; discussion 125-30. 综述

Konig K, Bockhorn V, Dietel W, Schubert H.
Photochemotherapy of experimental tumors in animals using various Photosensitizers.
Z Urol Nephrol. 1989 Nov;82(11):601-7. (德文)

Morgan AR, Rampersaud A, Garbo GM, Keck RW, Selman SH.
New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.
J Med Chem. 1989 Apr;32(4):904-8.

Reed MW, Schuschke DA, Ackermann DM, Harty JI, Wieman TJ, Miller FN.
The response of the rat urinary bladder microcirculation to photodynamic therapy.
J Urol. 1989 Sep;142(3):865-8.

TOP


 1988年

Amano T, Prout GR Jr, Lin CW.
Intratumor injection as a more effective means of porphyrin administration for photodynamic therapy.
J Urol. 1988 Feb;139(2):392-5.

Lin CW, Amano T, Rutledge AR, Shulok JR, Prout GR Jr.
Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative.
Cancer Res. 1988 Nov 1;48(21):6115-20.

Manyak MJ, Matthews DM, Smith PD, Nochomovitz LE, Glatstein E, Russo A.
Response of normal canine ureter to photodynamic therapy using a cylindrical fiber.
J Urol. 1988 Jan;139(1):199-203.

Morgan AR, Garbo GM, Keck RW, Selman SH.
New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors.
Cancer Res. 1988 Jan 1;48(1):194-8.

Nseyo UO, Dougherty TJ, Boyle DG, Potter WR.
Study of factors mediating effect of photodynamic therapy on bladder in canine bladder model.
Urology. 1988 Jul;32(1):41-5.

Uchibayashi T, Hisazumi H, Amano T, Miyoshi N.
An experimental study of whole bladder wall photodynamic therapy using a light-scattering medium. A preliminary report.
Nippon Hinyokika Gakkai Zasshi. 1988 May;79(5):807-13. (日文)

Zhou CN. 光动力医学科技网
Electron microscopic observation on human bladder cancer tissue after photodynamic therapy.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1988 Jun;10(3):176-8. (中文)

Zhou CN, Xu BZ, Xie JG, Yang Y, Ding ZX, Yang WZ, Shen H, Chen Y, Ha XW:
An ultrastructural study of human bladder cancer treated by photodynamic therapy.
Lasers Med. Sci. 1988,3:87-92

TOP


 1987年

Morgan AR, Garbo GM, Kreimer-Birnbaum M, Keck RW, Chaudhuri K, Selman SH.
Morphological study of the combined effect of purpurin derivatives and light on transplantable rat bladder tumors.
Cancer Res. 1987 Jan 15;47(2):496-8.

Morgan AR, Rampersaud A, Keck RW, Selman SH.
Verdins: new photosensitizers for photodynamic therapy.
Photochem Photobiol. 1987 Sep;46(3):441-4.

Williams RD, Runge TC.
Photodynamic therapy of human bladder cancer cells in vitro correlated with cellular fluorescence levels of Photofrin-II.
Photochem Photobiol. 1987 Nov;46(5):733-7.

TOP


 1986年

Fan XJ, Xie JG, Lin PZ, Cui W, Zhang JS, Shen H, Ha XW, Okada M.
Photodynamic therapy (PDT) of bladder cancer in the rat.
Zhonghua Zhong Liu Za Zhi. 1986 May;8(3):181-3. (中文)

Nseyo UO, Mang TS, Potter WR.
Dihematoporphyrin ether clearance in primate bladders.
J Urol. 1986 Dec;136(6):1363-6.

Selman SH, Kreimer-Birnbaum M, Chaudhuri K, Garbo GM, Seaman DA, Keck RW, Ben-Hur E, Rosenthal I.
Photodynamic treatment of transplantable bladder tumors in rodents after pretreatment with chloroaluminum tetrasulfophthalocyanine.
J Urol. 1986 Jul;136(1):141-5.

Shulok JR, Klaunig JE, Selman SH, Schafer PJ, Goldblatt PJ.
Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.
Am J Pathol. 1986 Feb;122(2):277-83.

TOP


1985年

Cuthbert AW. 光动力医学科技网
Regulation of transepithelial ion transport by intracellular calcium ions.
Pflugers Arch. 1985;405 Suppl 1:S127-30.

Nseyo UO, Dougherty TJ, Boyle D, Potter W, Englander LS, Huben RP, Pontes JE.
Experimental photodynamic treatment of canine bladder.
J Urol. 1985 Feb;133(2):311-5.

Selman SH, Kreimer-Birnbaum M, Keck RW, Milligan AJ, Goldblatt PJ, Britton S.
Correlation of tumor blood flow to tumor regression after hematoporphyrin derivative (HPD) photodynamic therapy to transplantable bladder tumors.
Adv Exp Med Biol. 1985;193:97-103.

TOP


 1984年

Bellnier DA, Lin CW. 光动力医学科技网
Photodynamic inactivation of cultured bladder tumor cells: a preliminary study of the effects of porphyrin aggregation.
Prog Clin Biol Res. 1984;170:361-71.

Ishikawa S, Nemoto R, Kanoh S, Kobayashi K, Ishizaka S.
Photodynamic inactivation of bladder cancer cells (MGH-U1) sensitized with acridine orange and irradiated by argon laser.
Tohoku J Exp Med. 1984 Nov;144(3):265-71.

Hisazumi H, Miyoshi N, Ueki O, Nakajima K.
Cellular binding of hematoporphyrin derivative (HpD) in human bladder cancer cell line: KK-47.
Prog Clin Biol Res. 1984;170:443-57.

TOP

 
     
 
 

关于我们联系方式访客留言相关条款设为首页加入收藏 联系我们

光动力医学科技网 版权所有 Copyright © 2002-2006, All Rights Reserved .
ICP备案号:粤ICP备05010795号
互联网药品信息服务资格证书:(粤)-非经营性-2004-0012
网络实名:光动力 本站网络实名:光动力 光化导弹 光动力医学科技 光动力疗法

警告:除非明确声明,本站内容的所有权利和利益(包括但不限于版权)归PDT-MED所有
.
未经PDT-MED书面许可,禁止以任何形式或媒体进行全部或部分复制,对本网站的任何使用应遵守我们的使用条款